Experimental animal models of osteonecrosis

Meng Fan1, Jiang Peng, Ling Qin

  • 1Medical College, NanKai University, Tianjin, China.

Rheumatology International
|February 23, 2011
PubMed

Insights

Developing effective treatments for osteonecrosis (ON), or avascular necrosis (AVN), requires ideal animal models. This review details methods for creating ON models to better compare treatment efficacy for femoral head osteonecrosis (ONFH).

Area of Science:

  • Orthopedics
  • Bone Metabolism
  • Preclinical Research

Background:

  • Osteonecrosis (ON), also known as avascular necrosis (AVN), is a debilitating bone disorder frequently affecting the femoral head.
  • Current treatments for femoral head osteonecrosis (ONFH) lack consensus and satisfactory outcomes, partly due to the absence of ideal preclinical models.
  • A critical need exists for reproducible animal models that accurately mimic human ONFH, including joint collapse and adjacent reparative responses.

Purpose of the Study:

  • To systematically review and describe various methods for creating experimental animal models of osteonecrosis.
  • To discuss the advantages and disadvantages of existing ON models.
  • To provide a reference for selecting appropriate models to advance ONFH research and treatment development.

Main Methods:

  • Review of established methodologies for inducing osteonecrosis in animal models.
  • Comparative analysis of different ON model systems.
  • Discussion of model characteristics relevant to mimicking human ONFH pathology.

Main Results:

  • Several distinct methods exist for generating animal models of osteonecrosis.
  • Each model possesses unique advantages and limitations regarding reproducibility, incidence of collapse, and simulation of reparative reactions.
  • No single model perfectly replicates all aspects of human ONFH.

Conclusions:

  • The development and selection of appropriate animal models are crucial for advancing the understanding and treatment of osteonecrosis.
  • Further refinement of existing models or development of novel ones is necessary to facilitate systematic comparison of therapeutic interventions.
  • Improved preclinical models will accelerate the translation of effective ONFH treatments to clinical practice.

Related Concept Videos